Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Michigan Rogel Cancer Center
With
Otsuka Pharmaceutical Development & Commercialization, Inc.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Biologic high risk Multiple Myeloma:
* Stage II/III Multiple Myeloma, any of: t(4; 14), t(14; 16),(14:20) by Fish; 17P- by conventional cytogenetics or Fish; ∆13 by conventional cytogenetics; Hypodiploidy by conventional cytogenetics.
* Relapsed or persistent multiple myeloma after ASCT.
* Persistent multiple myeloma, regardless of previous therapies.
* Plasma cell leukemia, regardless of previous therapies.
Age up to 70 years old (less than 71 years old at the date of transplant admission).
Disease status: in CR, nCR, VGPR, PR or stable disease within 1 month of admission
Specific renal, liver, cardiac, and pulmonary function requirements(all must be met within 30 days of transplant admission)
You may not be if
Persistent invasive infections, not controlled by antimicrobials.
HIV-1/HIV-2 or HTLV-1/HTLV-2 seropositivity.
Uncontrolled medical or psychiatric disorder.
No response or progressive disease at the time of transplantation.